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ABSTRACT. Sulfathiazole (SFTZ) is a sulfonamide used for the treatment of bacterial infection. The cobalt 
complex of sulfathiazole was synthesized by reaction of sulfathiazole with CoCl2.6H2O. The metal complex was 
characterized based on AAS, UV, IR, 1H NMR spectroscopy and X-ray powder diffraction. The electronic 
spectrum of the ligand showed intra ligand charge transfer (ILCT) which were assigned to the chromophores 
present in the ligand, while that of the complex suggested intra ligand charge transfer (ILCT) and ligand to metal 
charge transfer (LMCT). The IR spectra of the complexes showed the involvement of amine, sulfonyl and cyano 
group in coordination to the metal ion. This showed that sulfathiazole acted as a tridentate ligand. 1H NMR 
spectrum of [Co(SFTZ)] complex further showed the involvement of the amine and sulfonyl group in coordination 
to the metal ions. The structure of [Co(SFTZ)] complex was assigned as trigonal. The crystal structure of 
[Co(SFTZ)] complex belongs to cubic system, space group P1, with cell parameters of a = 4.007 Å, b = 5.0078 Å, 
c = 5.9844 Å,   = 30.61 Å3, α = 90o, β  90o, γ = 90o. Molecular docking suggested that the ligand/complex binded 
effectively with the E. Coli and S. aureus because their global binding energies were negative. The binding 
interactions of ligand/complex with E. Coli and S. Aureus were predicted. Molecular docking predicted the 
feasibility of the biochemical reactions before experimental investigation. 
  




Sulfathiazole (SFTZ) and their metal complexes possess antibacterial activity, diuretic, 
antiglaucoma, antiepileptic, antifungal activity [1-2] and, in many cases, the activity of the metal 
complex is much better than the ligand alone [1-2]. Studies on their metal chelates could have 
much physiological and pharmacological relevance because the metal chelates of sulfadrugs 
have been found to be more bacteriostatic than the drugs themselves [3-4]. The role of metal 
ions in living systems has been well established in recent years. The use of transition metal 
complexes as medicinal compounds has become more and more prominent. These complexes 
offer a great diversity in their action; they do not only have anti-cancer properties but have also 
been used as anti-inflammatory [5], anti-infective [6] and anti-diabetic compounds [7].  
Metal ions play pivotal roles in many biological processes, and the study of the roles of 
these metal ions in biological systems falls into the rapidly developing interdisciplinary field 
known as bioinorganic chemistry. When compared to other branches of natural sciences, 
bioinorganic chemistry seems to be an interesting discipline. However, there is a copious 
amount of information on the effects of metals on biological systems. For instance, the toxicities 
of metal ions such as mercury, lead and chromium on the environment have been reported [8-9].  
Metal chelation is a brilliant way to increase the lipophilic character of the organic moiety. 
Infact, on coordination, ligands would possibly improve their bioactivity profiles whereas some 
inactive ligands could acquire medicinal properties and consequently they have become a very 
important category of structure-selective binding agents for nucleic acids [10-11]. 
Otuokere Ifeanyi Edozie et al. 
Bull. Chem. Soc. Ethiop. 2020, 34(1) 
84
Various Co(III) complexes have been reported with antimicrobial activities. For instance, a 
Co(III) complex of the known antiulcer drug famotidine turned out to have greater antimicrobial 
activity against E. coli and M. lysodeikticusthan the metal free drug [12]. The pyrazine-2,3-
dicarboxylate complexes of 1,10-phenanthroline and alkyl diamines have recently shown 
activity against Gram(+) and Gram(-) bacterial strains and fungi C. albicans. The cobalt(II) 
complexes of hinikitiol, 4-isopropyltropolone, appeared to be active, in comparison to copper(II) 
complexes [13-14] 
Interesting biological properties have been found in the series of metal(II) oxinates of the 
derivative of sulfonohydrazide, belonging to the group of sulfonamides. The octahedral cobalt 
complex possessed good activity against both Gram(+) and Gram(-) bacterial strains but not 
higher than the free ligand alone [15]. Cobalt(II) complexes not only show antimicrobial but 
also antifungal activities. The complex of the imidazole-2-carbaldehyde semicarbazone turned 
out to be active against the yeasts S. cerevisiae and C. tropicalis. Activity was most noticeable 
against such phyto pathogenic fungi as Alternaria or Sclerotinia. Moreover, several cobalt(II) 2-
methylthionicotinate complexes of various N-heterocyclic ligands showed significant activity 
against bacterial strains and fungi. It turned out that complexation of the nicotinate derivatives 
led to an elevation of their biological activity [16]. 
Cobalt(II) complexes of the Schiff bases had been developed for their antimicrobial and 
antifungal properties. Polyether ionophore antibiotics of Monensin produced by Streptomyces 
are biologically active compounds. The simple Co3+ ion is unstable in water, but can be 
stabilized against reduction to Co2+ by coordination to ligands or chelators. The chelating N,O 
donor ligand is by far the most common ligand type used to stabilize the cobalt(III) ion in 
aqueous solution. Amazingly, cobalt(III) complexes derived from this ligand donor set have 
found application as antibacterial or antiviral agents [15]. One of the most promising classes of 
Co(III) complexes containing N,O donor ligands is the 2-methylimidazole complex. In 1998, 
Epstein and coworkers reported that the cobalt complex of 2-methylimidazole was effective in 
the treatment of epithelial herpetic keratitis, one of the major causes of blindness in industrial 
nations [17]. Spectral characterization and antimicrobial activity of some transition metal 
complexes of 2-(5-nitro-1H-benzimidazol-2-yl)-4-bromophenol have been reported [18]. 
Synthesis, X-ray analysis and antibacterial study of silver complex with ethyl-5-hydroxy-2-oxo-
2H-chromene-3-carboxylate have also been reported [19]. 




All chemicals and reagents used in the experimental work were of analytical grade. Melting 
points of the complex was determined using MPA160 melting point apparatus. Percentage of Co 
was determined using atomic absorption spectroscopy Duck-2010 spectrometer (Duck 
instrumental company) [14]. Infrared spectra were collected on Perkin Elmer Paragon 1000 FT-
IR spectrophotometer (spectrum BX) equipped with cesium iodide window (4000-350 cm-1) in 
KBr pellets. The UV-Visible spectra were obtained on a Perkin Elmer (lambda 25) spectrometer 
(200-800 nm) using DMSO as solvent. The 1H nuclear magnetic resonance (NMR) spectra were 
obtained using Varian 400 MHz Unity INOVA. 
 
Synthesis of sulfathiazole and its metal complex 
 
The complex was prepared following a reported procedure [20]. Co(II) salt solution was 
prepared by dissolving 4.94 g (0.02 mol) CoCl2.6H2O in 25 mL of distilled water. The solution 
of the metal salt was added slowly with stirring in a separate 20 mL of distilled water containing 
5.1 g of sulfathiazole (0.02 mol) at room temperature maintaining the pH between 6.0-6.5 by 
adding dilute solution of KOH. The synthesis was carried out with stirring at room temperature. 
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After 1 hour, the complex separated out. The complex was washed well with distilled water, 




The three-dimensional structure of Escherichia coli and Staphylococcus aureus were obtained 
from the Protein Data Bank, PDB 1E91 and 1STN, respectively. The protein structures were 
subjected to a refinement protocol using Molegro Molecular Viewer. Molecular docking was 
performed using Patch Dock Server: an automatic server for molecular docking [22]. 
Refinement was done in Fire Dock Server: An automatic server for fast interaction refinement in 
molecular docking and processed with Molegro molecular viewer [22-25]. 
 
X-Ray crystal structure determination 
 
Appropriate amounts of the crystals were collected and deposited on Bruker D8 diffractometer 
operating in transmission mode using germanium monochromated CuKα1 radiation, λ = 1.5406 
Å, linear position-sensitive detector covering 12o in 2θ, 2θ  mode range 3.5o –70o, step size 
0.017o and 17 h data collection time. FOX software was used for structure determination and 
refinement.  
C9H9N3O2S2 + Co2+ [(C9H9N3O2S2)Co]
2+
 
Scheme 1. Synthesis scheme of the metal complex. 
 
RESULTS AND DISCUSSION 
 
Crystallographic data and structure refinement parameters for the metal complex are given in 
Table 1. The indexed powdered X-ray diffraction peaks is shown in Figures 1. 
 
Table 1. Crystal data and structure refinement for [Co(SFTZ)]. 
 
Crystal data [Co(SFTZ)]                          
Temperature (K) 298 
Wavelength (Å) 0.71073 
Crystal system Cubic 
Space group P 1 
a (Å) 4.0070 
b (Å) 5.0078 
c (Å) 5.9844 
α (°) 90° 
β (°) 90° 
γ (°) 90° 
Volume (Å3) 30.61 (1.0 V) 
 
The crystal structure of [Co(SFTZ)] complex belongs to cubic system, space group P1, with 
cell parameters of a = 4.007 Å, b = 5.0078 Å, c = 5.9844 Å,   = 30.61 Å3, α = 90o, β  90o, γ = 
90o. 
The percentage of Co in the complex was 18.67%. This was in agreement with the 
calculated value of   18.81%.  This showed that the experimental values are in agreement with 
the calculated values. The purple colour of [Co(SFTZ)] suggested the formation of complex 
because transition metal complexes are coloured. The change in melting point from 203 oC 
(SFTZ) to 235 oC [Co(SFTZ)] also indicated the formation of a new complex. 
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Figure 2. Infrared spectra of sulfathiazole and its Co(II) complex. 
 
A comparison of IR spectra of SFTZ [21] and [Co(SFTZ)] complex was made (Figure 2). 
The infrared spectrum of SFTZ showed a broad band at 3354.00 and 3321.00 cm1. This band 
was assigned N-H stretch of the primary amine due to asymmetric and symmetric stretching 
vibrations of the two N-H bonds. In the IR spectrum of the metal complex, this vibration 
frequency remained unchanged. This suggested that NH2 was not involved in complexation. 
Vibration frequencies at 1323.00 cm1 and 1140.00 cm1 were assigned to be as (O=S=O) and 
s (O=S=O) in SFTZ. In the complex, these frequencies appeared at 1268.37, 1128.39 cm
1 
[Co(SFTZ)]. The shift to lower wave number in the IR spectrum of the complex when compared 
to the ligand suggested that complexation occurred through O=S=O to the Co ion because 
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the vibration frequency [26]. It is evident that sulfonyl group was involved in coordination to 
Co. In SFTZ spectrum, C-N stretching vibration was observed at 1497.00 cm1. In the IR 
spectrum of the complex, this functional group was observed at 1454.06 cm1. This observation 
also suggested coordination through C-N moiety. This is because increase in electron density 
increased the C-N bond length and consequently slowed down the vibration frequency. The N-H 
stretch of SO2NH appeared at 3255.23 cm
1 in the free ligand. In the IR spectrum of the metal 





Figure 3. UV-Vis spectra of sulfathiazole and its Co(II) complex. 
 
The UV/visible spectrum of sulfathiazole and [Co(SFTZ)] are presented in Figure 3. The 
UV-Vis spectrum of SFTZ showed a band centered at 269 nm. It was assigned π-π* due to intra-
ligand charge transfer (ILCT). The UV-Vis spectrum of [Co(SFTZ)] showed a band at 269 nm 
which was assigned to be π-π* due to intra-ligand charge transfer (ILCT). The sharp band 
centered at 350 nm was assigned to be ligand to metal charge transfer (LMCT). The broad band 
at 600 nm was due to d-d transition which suggested that complexation occurred. 
The 1H-NMR spectra of SFTZ [21] and [Co(SFTZ)] are presented in Figure 4. In the 1H 
NMR spectrum of SFTZ [21] (Figure 4), the aromatic protons appeared at 6.51-7.43 ppm while 
the thiazole protons are observed between 6.71-7.18 ppm. NH2 protons were observed at 5.80 
ppm. In the spectrum of the [Co(SFTZ)] complex (Figure 4), these chemical shifts were 
unchanged. In the 1H NMR spectrum of SFTZ, the hydrogen that appeared as a singlet at 12.4 
ppm is no longer observed in the spectrum of the [Co(SFTZ)] complex. This was attributed to 
the loss of hydrogen atom of the (O2S-N-H) group of SFTZ when coordination occurred through 
the nitrogen to the metal centre. 
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Figure 4. 1H NMR spectra of sulfathiazole and its Co(II) complex. 
 
Based on the UV, IR, 1H NMR spectra and X-ray powder diffraction,  a trigonal structure 
have been proposed for [Co(SFTZ)] (Figure 5). Cobalt complexes have been known to exhibit 








Figure 5. Proposed structure of sulfathiazole cobalt complex. 
 
The crystal structure of E. coli contains four protein chains (A, B, C and D) and 506 water 
molecules. The crystal structure of S. aureus nuclease is made up of one protein chain (A) and 
83 water molecules. The molecular docking and molecular interactions of sulfathiazole and 
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Figure 6. Molecular docking and molecular interactions of sulfathiazole with E. coli. (Binding 















Figure 7. Molecular docking and molecular interactions of  [Co(SFTZ)] complex with E. coli . 














Figure 8. The molecular docking and molecular interactions of sulfathiazole with S. aureus. 
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Figure 9. The molecular docking and molecular interactions of [Co(SFTZ)] complex with S. 
aureus. (Binding energy -26.59 kcal/mol). 
 
The best global energy in Figure 6 is -46.74 kcal/mol. This suggested that sulfathiazole had 
the ability to inhibit E. coli. The attractive Van der Waals and atomic contact energy (ACE) 
showed negative values. These suggested that sulfathiazole docked effectively with E. coli. The 
molecular interactions (Figure 6) showed that E. coli formed hydrogen bonding with 
sulfathiazole using Ala 247 (C) and Glu 250 (C). Steric interaction between E. coli and 
sulfathiazole were observed with Gly 156 (C), Glu 157 (C), Asn 161 (C), Ala 260 (C), Asn 162 
(C), Val 163 (C), and Asp 164 (C). The best global energy in Figure 7 is -38.52 kcal/mol. This 
suggested that [Co(SFTZ)] had the ability to inhibit E. coli. The attractive Van der Waals and 
atomic contact energy (ACE) were also predicted. Their negative values predicted effective 
binding. The molecular interactions (Figure 7) showed that E. coli formed hydrogen bonding 
with [Co(SFTZ)] via Glu 250 (C). Steric interactions between [Co(SFTZ)] and E. coli occured 
with Ala 247 (C), Tyr 257 (C), Val 258 (C), Ala 248 (C) and Glu 157 (C). The best global 
energy in Figure 8 is -25.35 kcal/mol. This suggested that sulfathiazole had the ability to inhibit 
S. aureus. The attractive Van der Waals and atomic contact energy (ACE) showed negative 
values. These suggested that sulfathiazole docked effectively with S. aureus. The molecular 
interactions (Figure 8) showed that S. aureus formed hydrogen bonding with sulfathiazole using 
HOH 225 (A) and HOH 291 (A). Steric interaction between S. aureusand sulfathiazole were 
observed with Gln 80, Lys 116, Tyr 115 and Pro 117. The best global energy in Figure 9 is         
-26.59 kcal/mol. This suggested that [Co(SFTZ)] had the ability to inhibit S. aureus. The 
attractive Van der Waals and atomic contact energy (ACE) showed negative values. These 
suggested that [Co(SFTZ)] docked effectively with S. aureus. The molecular interactions 
(Figure 9) showed that S. aureus formed hydrogen bonding with [Co(SFTZ)] using HOH 223 
(A), HOH 225 (A) and HOH 291 (A). Steric interaction between S. aureus and [Co(SFTZ)]  




The ability of sulfathiazole to sequestrate Co(II) has been assured. Sulfathiazole can be used to 
extract Co(II) from solution. Molecular docking also suggest that [Co(SFTZ)] complex will be a 
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